XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income / (loss) from continuing operations $ (720,000) $ (1,389,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 211,000 291,000
Equity compensation expense 16,000 153,000
Change in assets and liabilities:    
Accounts receivable 685,000 2,032,000
Inventories (203,000) (1,286,000)
Prepaid expenses and other assets (22,000) 562,000
Trade payables 87,000 (54,000)
Accrued liabilities (496,000) 878,000
Net cash (used in) provided by operating activities (442,000) 1,187,000
Cash flows from investing activities:    
Purchases of property, plant and equipment (136,000) (121,000)
Net cash (used in) investing activities (136,000) (121,000)
Cash flows from financing activities:    
Proceeds from issuance/(Repayment) of long-term debt and revolving line of credit 496,000 (1,031,000)
Net cash provided by (used in) financing activities 496,000 (1,031,000)
Net (decrease) / increase in cash and cash equivalents (82,000) 35,000
Cash and cash equivalents at beginning of period 146,000 66,000
Cash and cash equivalents at end of period 64,000 101,000
Supplemental disclosure of cash flow information:    
Cash payments for interest 364,000 265,000
Accrued Divided and Accretion on preferred stock 11,000 550,000
Lease right-of-use assets and lease liability 747,000
Conversion of notes and deposits into common stock 885,000
Conversion of Series B preferred stock into common stock $ 1,500,000 $ 6,745,000